[Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension].

Primary biliary cholangitis (PBC) is a type of autoimmune liver disease characterized by chronic intrahepatic cholestasis. Although portal hypertension is a common complication in patients with cirrhotic PBC, portal hypertension and its related complications can occur in the early stage of the disease, that is, before the cirrhosis onset. Therefore, early identification and long-term management are of great significance to reduce the occurrence of portal hypertension and decompensation events and improve long-term prognosis in patients with PBC. This paper focuses on the epidemiology, pathophysiological mechanism, clinical characteristics, non-invasive diagnosis, and treatment strategies for portal hypertension in early-stage PBC patients.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-07-20
DOI
https://doi.org/10.3760/cma.j.cn501113-20250505-00172
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension].

Jidong Jia, Lu Shen, Li Ma, S X Li et al.
PubMed
Liver Diseases and Immunity
article

[Research progress on early-stage primary biliary cholangitis accompanied by portal hypertension].

Jidong Jia, Lu Shen, Li Ma, S X Li, Hong You, Wei Duan
article en

Abstract

Primary biliary cholangitis (PBC) is a type of autoimmune liver disease characterized by chronic intrahepatic cholestasis. Although portal hypertension is a common complication in patients with cirrhotic PBC, portal hypertension and its related complications can occur in the early stage of the disease, that is, before the cirrhosis onset. Therefore, early identification and long-term management are of great significance to reduce the occurrence of portal hypertension and decompensation events and improve long-term prognosis in patients with PBC. This paper focuses on the epidemiology, pathophysiological mechanism, clinical characteristics, non-invasive diagnosis, and treatment strategies for portal hypertension in early-stage PBC patients.

PubMedVol. 33(7)
National Clinical Research Center for Digestive Diseases (CN)
National Natural Science Foundation of China, Natural Science Foundation for Young Scientists of Shanxi Province, Young Scientists Fund
Openalex Percentile: Top 71%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.